nach oben

Cancer Immunology, Immunotherapy

Erschienen in:

01.01.2005 | Original Article

Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: the IL-15/IL-15Rα complex and CD4⁺CD25⁺ T cells are the main targets

verfasst von: Virginie Forest, Fabrice Pierre, Euphémie Bassonga, Khaled Meflah, Jean Menanteau

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

We have shown recently that some indigestible carbohydrate (short-chain fructo-oligosaccharides [sc-FOS]) reduced colon tumor incidence in Apc+/Min mice, and that this effect depended on a functional local immune system. In addition, IL-15 mRNA was concomitantly modulated in the mucosa. Since intraepithelial lymphocytes (IELs) are in close contact with intestinal epithelial cells, these cells are the candidates most likely to be involved in early cancer immunosurveillance. The present study documents the effects of sc-FOS on large intestine IELs (LI-IELs) from Apc+/+ or Apc+/Min mice by analyzing markers related to their phenotype, their activation status, and the cell surface IL-15/IL-15Rα. In the colons of Apc+/Min mice, fewer LI-IELs expressed surface IL-15/IL-15Rα. In addition, a lower number of CD4⁺ LI-IELs expressed CD25, although more LI-IELs expressed CD69, as compared to normal mice. The sc-FOS–enriched diet caused a decrease in the proportion of CD25⁺ LI-IELs and an increase in the percentage of LI-IELs bearing surface IL-15/IL-15Rα, independently of the Apc gene status. The IL-15/IL-15Rα increase was, however, higher in Min mice, and returned to a level very similar to that of Apc+/+ mice when the latter mice were fed a low-fiber diet. The sc-FOS-enriched diet specifically induced an increase in CD69⁺ cells in Apc+/+ mice, and a decrease in the proportion of CD4⁺CD25⁺ LI-IELs in Apc+/Min mice. Some of these modulations could contribute to the development of a better immune anticancer response in the early steps of cancer development.

Bassonga E, Forest V, Pierre F, Bornet F, Perrin P, Meflah K, Menanteau J (2001) Cytokine mRNA expression in mouse colon: IL-15 mRNA is overexpressed and is highly sensitive to a fibre-like dietary component (short-chain fructo-oligosaccharides) in an Apc gene manner. Cytokine 14:243–246CrossRefPubMed

Beagley KW, Husband AJ (1998) Intra-epithelial lymphocytes: origin, distribution and function. Crit Rev Immunol 18:237–254PubMed

Beagley KW, Fujihashi K, Lagoo AS, Lagoo-Deenadaylan S, Black CA, Murray AM, Sharmanov AT, Yamamoto M, McGhee JR, Elson CO, Kiyono H (1995) Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. J Immunol 154:5611–5619PubMed

Berard M, Brandt K, Bulfone Paus S, Tough DF (2003) IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol 170:5018–5026PubMed

Boll G, Rudolph A, Spieb S, Reiman J (1995) Regional specialization of intraepithelial T cells in the murine small and large intestine. Scand J Immunol 41:103–113PubMed

Bonnafe M, Valensin S, Gianni W, Marigliano V, Franceschi C (2001) The unexpected contribution of immunosenescence to the leveling off of cancer incidence and mortality in the oldest old. Crit Rev Oncol/Hematol 39:227–233

Bulanova E, Budagian V, Pohl T, Krause H, Dürkop H, Paus R, Bulfone-Paus R (2001) The IL-15Rα chain signals through association with syk in human B cells. J Immunol 167:6292–6302PubMed

Burkett PR, Koka R, Chien M, Chai S, Chan F, Ma A, Boone DL (2003) IL-15Rα expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci U S A 100:4724–4729CrossRefPubMed

Camerini V, Panwala C, Kronenberg M (1993) Regional specialization of the mucosal immune system: intraepithelial lymphocytes of the large intestine have a different phenotype and function than those of the small intestine. J Immunol 151:1765–1776PubMed

10.

Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA (1997) A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 99:937–943

11.

De Winter H, Elewaut D, Turovskaya O, Huflejt M, Shimeld C, Hagenbaugh A, Binder S, Takahashi I, Kronenberg M, Cheroutre H (2002) Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterology 122:1829–1841PubMed

12.

Dubois S, Magangeas F, Lehours P, Raher S, Bernard J, Boisteau O, Leroy S, Minville S, Godard A, Jacques Y (1999) Natural splicing of exon 2 of human interlukin-15 receptor α-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem 274:26978–26984CrossRefPubMed

13.

Dubois S, Mariner J, Waldmann TA, Tagaya Y (2002) IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17:537–547

14.

Ebert EC (1998) Interleukin-15 is a potent stimulant of intra-epithelial lymphocytes. Gastroenterology 115:1439–1445PubMed

15.

Goldin BR (1984) In situ bacterial metabolism and colon mutagens. Annu Rev Microbiol 40:367–393CrossRef

16.

Gunn GR, Zubair A, Peters C, Pan Z-K, Wu TC, Paterson Y (2001) Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 167:6471–6479PubMed

17.

Guy-Grand D, Vassalli P (2002) Gut intra-epithelial T lymphocytes. Curr Opin Immunol 14:255–259CrossRefPubMed

18.

Hayday A, Theodoris E, Ramsburg E, Shires J (2001) Intra-epithelial lymphocytes: exploring the third way in immunology. Nat Immunol 2:997–1003CrossRefPubMed

19.

Ibraghimov AR, Lynch RG (1994) Heterogeneity and biased T cell receptor α/β repertoire of mucosal CD8+ cells from murine large intestine: implications for functional state. J Exp Med 180:433–444CrossRefPubMed

20.

Inagaki-Ohara K, Nishimura H, Mitani A, Yoshikai Y (1997) Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing γδ T cell receptor in mice (1997) Eur J Immunol 276:2885–2891

21.

Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JCL, Joyce S, Peschon JJ (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191:771–780CrossRef

22.

Kettunen HL, Kettunen ASL, Rautonen NE (2003) Intestinal immune responses in wild-type and ApcMin/+ mouse, a model for colon cancer. Cancer Res 63:5136–5142PubMed

23.

Kinoshita N, Hiroi T, Ohta N, Fukuyama S, Park EJ, Kiyono H (2002) Autocrine IL-15 mediates intestinal epithelial cell death via the activation of neighboring intraepithelial NK cells. J Immunol 169:6187–6192PubMed

24.

Koka R, Burkett PR, Chien M, Chai S, Chan F, Lodolce JP, Boone DL, Ma A (2003) Interleukin (IL)-15Rα-deficient natural killer cells survive in normal but not IL-15Rα-deficient mice. J Exp Med 197:977–984CrossRefPubMed

25.

Kuniyashu H, Oue N, Nakae D, Tsutsumi M, Denda A, Tsujiuchi T, Yokozaki H, Yasui W (2001) Interleukin-15 expression is associated with malignant potential in colon cancer cells. Pathobiology 69:86–95CrossRefPubMed

26.

Kuo S, El Guindy A, Panwala CM, Hagan PM, Camerini V (2001) Differential appearance of T cell subsets in the large and small intestine. Pediatr Res 49:543–551PubMed

27.

Kursar M, Bonhagen K, Fensterle J, Köhler A, Hurwitz R, Kamradt T, Kaufmann SHE, Mittrücker H-W (2002) Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med 196:1585–1592CrossRefPubMed

28.

Lai Y-G, Gelfanov V, Gelfanova V, Kulik L, Chu C-L, Jeng S-W, Liao N-S (1999) IL-15 promotes survival but not effector function differentiation of CD8+TCRαβ+ intestinal intra-epithelial lymphocytes. J Immunol 163:5843–5850PubMed

29.

Lanier LL (2001) A renaissance for the tumor immunosurveillance hypothesis. Nat Med 7:1178–1180CrossRefPubMed

30.

Lasek W, Golab J, Maslinski W, Switaj T, Balkowiec EZ, Stoklosa D, Giermasz A, Malejczyk M, Jakobisiak M (1999) Subtherapeutic doses of interleukin-15 augment the anti-tumor effect of interleukin-12 in a B16F10 melanoma model in mice. Eur Cytokine Netw 10:345–356PubMed

31.

Lim BO, Yamada K, Nonaka M, Kuramoto Y, Hung P, Sugano M (1996) Dietary fibers modulate indices of intestinal immune function in rats. Am Soc Nutr Sci S166:663–667

32.

Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669–676CrossRefPubMed

33.

Lu J, Giuntoli RL, Omiya R, Kobayashi H, Kennedy R, Celis E (2002) Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes. Clin Cancer Res 8:3877–3884PubMed

34.

Meazza R, Lollini P-L, Nanni P, De Giovanni C, Gaggero A, Comes A, Cilli M, Di Carlo E, Ferrini S, Musiani P (2000) Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response. Int J Cancer 87:574–581CrossRefPubMed

35.

Meydani S, Ha W (2000) Immunologic effects of yoghurt. Am J Clin Nutr 71:861–872PubMed

36.

Moser AR, Henry CP, William FD (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322–324PubMed

37.

Munger W, Dejoy SQ, Jeyaseelan RS, Torley LW, Grabstein KH, Eisenmann J, Paxton R, Cox T, Wick MM, Kerwa SS (1995) Studies evaluating the anti-tumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol 165:289–293CrossRefPubMed

38.

Murakami M, Sakamoto A, Bender J, Kappler J, Marrack P (2002) CD25+ CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci U S A 99:8832–8837CrossRefPubMed

39.

Mysorekar IU, Lorenz RG, Gordon JI (2002) A gnotobiotic transgenic mouse model for studying interactions between small intestinal enterocytes and intra-epithelial lymphocytes. J Biol Chem 277:37811–37819CrossRefPubMed

40.

Nakamura K, Kitani A, Strober W (2001) Cell contact-dependent immunosuppression by CD4+CD25+ rgulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med 194:629–644CrossRefPubMed

41.

Ohtsuka K, Hasegawa K, Yamagiwa S, Sato K, Nakayama M, Watanabe H, Asakura H, Abo T (1996) Intra-epithelial lymphocytes in colon have similar properties to intra-epithelial lymphocytes in small intestine and hepatic intermediate TCR cells. Dig Dis Sci 41:902–911PubMed

42.

Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59:3128–3133PubMed

43.

Pereno R, Giron-Michel J, Gaggero A, Cazes E, Meazza R, Monetti M, Monaco E, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B (2000) IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene 19:5153–5162CrossRefPubMed

44.

Perrin P, Pierre F, Patry Y, Champ M, Berreur M, Pradal G, Bornet F, Meflah K, Menanteau J (2001) Only fibers promoting a stable butyrate-producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut 48:53–61CrossRefPubMed

45.

Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J (1997) Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 57:225–228PubMed

46.

Pierre F, Perrin P, Bassonga E, Bornet F, Meflah K, Menanteau J (1999) T cell status influences colon tumor occurrence in Min mice fed short chain fructo-oligosaccharides as a diet supplement. Carcinogenesis 20:1953–1956CrossRefPubMed

47.

Prehn RT, Prehn LM (1996) Immunostimulation of cancer versus immunosurveillance. Medicina (Buenos Aires) 56[Suppl 1]:65–73

48.

Prlic M, Blazar BR, Farrat MA, Jameson SC (2003) In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 197:967–976CrossRefPubMed

49.

Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK (1996) Intestinal epithelial cells both express and respond to interleukin-15. Gastroenterology 111:1706–1713PubMed

50.

Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP (2000) Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut 47:397–403CrossRefPubMed

51.

Shimizu J, Yamasaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD4+CD25+ T-cells: a common basis between tumor immunity and autoimmunity. J Immunol 163:5211–5218PubMed

52.

Shires J, Theodoridis E, Hayday AC (2001) Biological insights into TCRγδ+ and TCRαβ+ intra-epithelial lymphocytes provided by serial analysis of gene expression. Immunity 15:419–434CrossRefPubMed

53.

Sillett HK, Southgate J, Howdle PD, Trejdosiewicz LK (1999) Expression of activation and costimulatory elements by human intestinal intra-epithelial lymphocytes. Scand J Immunol 50:52–60CrossRefPubMed

54.

Singh J, Rivenson A, Tomita M, Shimamura M, Ishibashi N, Reddy BS (1997) Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the biomarkers of colon carcinogenesis. Carcinogenesis 18:833–841CrossRef

55.

Smyth MJ, Godfrey DI, Trapani JA (2001) A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2:293–299CrossRefPubMed

56.

Stewart T, Henderson R, Grayson H, Opeltz G (1997) Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin Cancer Res 3:51–55PubMed

57.

Sutmuller RPM, van Duivenvoorde LM, van Elsas A, Schumacher Ton NM, Wildenberg ME, Allison JP, Toes REM, Offringa R, Melief CJM (2001) Synergism of cytotoxic lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autorective cytotoxic T lymphocyte responses. J Exp Med 194:823–832CrossRefPubMed

58.

Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, Hanover J, Bamford R, Waldmann TA (1997) Generation of secretable and nonsecretable interleukin-15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci U S A 94:14444–14449CrossRefPubMed

59.

Tasaki K, Yoshida Y, Miyauchi M, Maeda T, Takenaga K, Kouzu T, Asano T, Ochiai T, Sakiyamna S, Tagawa M (2000) Transduction of murine colon carcinoma cells with interleukin-15 induces antitumor effects in immunocompetent and immunocompromised hosts. Cancer Gene Ther 7:255–261CrossRefPubMed

60.

Umesaki Y, Setoyama H, Matsumoto S, Imaoka A, Itoh K (1999) Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun 67:3504–3511PubMed

61.

Yoshikai Y (1999) The interaction of intestinal epithelial cells and intra-epithelial lymphocytes in host defense. Immunol Res 20:219–235PubMed

Titel: Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: the IL-15/IL-15Rα complex and CD4+CD25+ T cells are the main targets
verfasst von: Virginie Forest
Fabrice Pierre
Euphémie Bassonga
Khaled Meflah
Jean Menanteau
Publikationsdatum: 01.01.2005
Verlag: Springer-Verlag
Erschienen in: Cancer Immunology, Immunotherapy / Ausgabe 1/2005
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-004-0543-7

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: the IL-15/IL-15Rα complex and CD4⁺CD25⁺ T cells are the main targets

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2005

Prospective clinical trials of biotherapies in solid tumors: a 5-year survey

Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals

Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells

Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22

In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells

Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasms

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie